A method for evaluating the effects of allograft sterilization procedures on the viability of human fibroblasts.
D000666:Amphotericin B / Q000494:pharmacology; D002462:Cell Membrane / Q000648:ultrastructure; D002467:Cell Nucleus / Q000648:ultrastructure; D002470:Cell Survival / Q000187:drug effects; D003470:Culture Media; D004721:Endoplasmic Reticulum / Q000648:ultrastructure; D005347:Fibroblasts / Q000187:drug effects / Q000648:ultrastructure; D006801:Humans; D066298:In Vitro Techniques; D007612:Kanamycin / Q000494:pharmacology; D008055:Lipids / Q000032:analysis; D008854:Microscopy, Electron; D008928:Mitochondria / Q000648:ultrastructure; D009132:Muscles; D010406:Penicillins / Q000494:pharmacology; D010636:Phenols; D013194:Staining and Labeling; D013242:Sterilization / Q000379:methods*; D013307:Streptomycin / Q000494:pharmacology; D014184:Transplantation, Homologous / Q000379:methods*
D003470:Culture Media; D008055:Lipids; D010406:Penicillins; D010636:Phenols; D007612:Kanamycin; D000666:Amphotericin B; D013307:Streptomycin